Development and Validation of an RNA-Seq-Based Prognostic Signature in Neuroblastoma

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2019.01361
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA